Publikationen (49) Publikationen, an denen Forscher/innen teilgenommen haben

2025

  1. Mitoception, or transfer of normal cell mitochondria to cancer cells, reverses remodeling of store-operated Ca2+ entry in tumor cells

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1872, Núm. 1

  2. Monitoring ER Ca2+ by Luminescence with Low Affinity GFP-Aequorin Protein (GAP)

    Methods in molecular biology (Clifton, N.J.), Vol. 2861, pp. 141-153

2024

  1. Analysis of Meis2 knockout mice reveals Sonic hedgehog-mediated patterning of the cochlear duct

    Developmental Dynamics

  2. In vitro and in vivo calibration of low affinity genetic Ca2+ indicators

    Cell Calcium, Vol. 117

  3. Obesity-Associated Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 25, Núm. 16

  4. Using Fluorescent GAP Indicators to Monitor ER Ca2+

    Current Protocols, Vol. 4, Núm. 6

2023

  1. Docencia basada en la evidencia

    Innovación docente en Educación Superior: interacción, participación y colaboración (Universidad de Valladolid), pp. 247

  2. I Jornada Científica de Estudiantes de Fisioterapia UEMC. Proyecto de Innovación Educativa

    Conference proceedings CIVINEDU 2023: 7th International Virtual Conference on Educational Research and Innovation September 20-21, 2023

  3. Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  4. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer

    Frontiers in Oncology, Vol. 13

  5. Transcriptional Basis of Ca2+ Remodeling Reversal Induced by Polyamine Synthesis Inhibition in Colorectal Cancer Cells

    Cancers, Vol. 15, Núm. 5

  6. Use of aequorin-based indicators for monitoring Ca2+ in acidic organelles

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1870, Núm. 6

2022

  1. ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 41

  2. Faricimab, un anticuerpo dual para el tratamiento de la degeneración macular

    Actualidad en farmacología y terapéutica, Vol. 20, Núm. 2, pp. 140-142

  3. Hacia un mejor control terapéutico de la migraña

    Actualidad en farmacología y terapéutica, Vol. 20, Núm. 2, pp. 107-113

  4. Inactivation of Fgf3 and Fgf4 within the Fgf3/Fgf4/Fgf15 gene cluster reveals their redundant requirement for mouse inner ear induction and embryonic survival

    Developmental Dynamics, Vol. 251, Núm. 5, pp. 877-884

  5. Nueva indicación terapéutica de sacubitrilo/ valsartan para pacientes con insuficiencia cardíaca con fracción de eyección conservada

    Actualidad en farmacología y terapéutica, Vol. 20, Núm. 1, pp. 65-66

2021

  1. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe

    Methods in Molecular Biology (Humana Press Inc.), pp. 227-239

  2. Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype

    Cell Death and Disease, Vol. 12, Núm. 11

  3. Genetically engineered mice for combinatorial cardiovascular optobiology

    eLife, Vol. 10